ACADIA PHARMACEUTICALS INC. Stock-Based Compensation
ACADIA PHARMACEUTICALS INC. (ACAD) reported Stock-Based Compensation of $31.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $16.94M, a 18.13% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $14.70M, a 29.16% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.23M, a 26.65% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $13.18M, a 49.63% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $52.13M, a 22.24% decline from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $67.05M, a 0.95% increase from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $66.42M, a 2.61% decline from fiscal 2022.
- ACADIA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $68.20M, a 7.21% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $31.64M 10-Q · filed 2026-08-05 | $44.87M derived: sum of 3 quarters · filed 2026-08-05 | $58.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $14.70M 10-Q · filed 2026-05-07 | $27.93M derived: sum of 2 quarters · filed 2026-05-07 | $41.11M derived: sum of 3 quarters · filed 2026-05-07 | $55.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $13.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.41M derived: sum of 2 quarters · filed 2026-02-26 | $40.76M derived: sum of 3 quarters · filed 2026-08-05 | $52.13M 10-K · filed 2026-02-26 |
| 2025-09-30 | $13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $27.52M derived: sum of 2 quarters · filed 2026-08-05 | $38.90M 10-Q · filed 2025-11-06 | $49.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $14.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $25.72M 10-Q · filed 2026-08-05 | $36.17M derived: sum of 3 quarters · filed 2026-08-05 | $62.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $11.38M 10-Q · filed 2026-05-07 | $21.83M derived: sum of 2 quarters · filed 2026-05-07 | $47.99M derived: sum of 3 quarters · filed 2026-05-07 | $63.68M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $10.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.61M derived: sum of 2 quarters · filed 2026-02-26 | $52.30M derived: sum of 3 quarters · filed 2026-02-26 | $67.05M 10-K · filed 2026-02-26 |
| 2024-09-30 | $26.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $41.85M derived: sum of 2 quarters · filed 2025-11-06 | $56.60M 10-Q · filed 2025-11-06 | $74.62M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $15.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $30.43M 10-Q · filed 2025-08-07 | $48.46M derived: sum of 3 quarters · filed 2026-02-26 | $67.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $14.75M 10-Q · filed 2025-05-08 | $32.77M derived: sum of 2 quarters · filed 2026-02-26 | $51.31M derived: sum of 3 quarters · filed 2026-02-26 | $66.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $18.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.56M derived: sum of 2 quarters · filed 2026-02-26 | $51.72M derived: sum of 3 quarters · filed 2026-02-26 | $66.42M 10-K · filed 2026-02-26 |
| 2023-09-30 | $18.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $33.69M derived: sum of 2 quarters · filed 2024-11-07 | $48.40M 10-Q · filed 2024-11-07 | $62.81M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $15.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $29.86M 10-Q · filed 2024-08-07 | $44.27M derived: sum of 3 quarters · filed 2025-02-27 | $62.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $14.71M 10-Q · filed 2024-05-09 | $29.12M derived: sum of 2 quarters · filed 2025-02-27 | $47.43M derived: sum of 3 quarters · filed 2025-02-27 | $67.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $14.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $32.73M derived: sum of 2 quarters · filed 2025-02-27 | $53.24M derived: sum of 3 quarters · filed 2025-02-27 | $68.20M 10-K · filed 2025-02-27 |
| 2022-09-30 | $18.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $38.82M derived: sum of 2 quarters · filed 2023-11-03 | $53.79M 10-Q · filed 2023-11-03 | $66.67M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $20.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $35.48M 10-Q · filed 2023-08-03 | $48.35M derived: sum of 3 quarters · filed 2024-02-28 | $63.90M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $14.96M 10-Q · filed 2023-05-08 | $27.84M derived: sum of 2 quarters · filed 2024-02-28 | $43.39M derived: sum of 3 quarters · filed 2024-02-28 | $65.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $28.43M derived: sum of 2 quarters · filed 2024-02-28 | $50.43M derived: sum of 3 quarters · filed 2024-02-28 | $63.62M 10-K · filed 2024-02-28 |
| 2021-09-30 | $15.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $37.55M derived: sum of 2 quarters · filed 2022-11-03 | $50.73M 10-Q · filed 2022-11-03 | $71.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $35.19M 10-Q · filed 2022-08-09 | $56.38M derived: sum of 3 quarters · filed 2023-02-28 | $77.76M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $13.18M 10-Q · filed 2022-05-05 | $34.38M derived: sum of 2 quarters · filed 2023-02-28 | $55.75M derived: sum of 3 quarters · filed 2023-02-28 | $75.26M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $21.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $42.57M derived: sum of 2 quarters · filed 2023-02-28 | $62.07M derived: sum of 3 quarters · filed 2023-02-28 | $84.42M 10-K · filed 2023-02-28 |
| 2020-09-30 | $21.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $40.88M derived: sum of 2 quarters · filed 2021-11-09 | $63.23M 10-Q · filed 2021-11-09 | $82.99M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $19.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $41.85M 10-Q · filed 2021-08-05 | $61.62M derived: sum of 3 quarters · filed 2022-03-01 | $83.81M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $22.35M 10-Q · filed 2021-05-06 | $42.11M derived: sum of 2 quarters · filed 2022-03-01 | $64.31M derived: sum of 3 quarters · filed 2022-03-01 | $84.73M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $19.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $41.96M derived: sum of 2 quarters · filed 2022-03-01 | $62.38M derived: sum of 3 quarters · filed 2022-03-01 | $82.27M 10-K · filed 2022-03-01 |
| 2019-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $42.62M derived: sum of 2 quarters · filed 2020-11-04 | $62.50M 10-Q · filed 2020-11-04 | $82.90M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $20.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $40.30M 10-Q · filed 2020-08-06 | $60.71M derived: sum of 3 quarters · filed 2021-02-25 | $80.88M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $19.88M 10-Q · filed 2020-05-08 | $40.28M derived: sum of 2 quarters · filed 2021-02-25 | $60.45M derived: sum of 3 quarters · filed 2021-02-25 | $81.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $40.57M derived: sum of 2 quarters · filed 2021-02-25 | $61.12M derived: sum of 3 quarters · filed 2021-02-25 | $81.56M 10-K · filed 2021-02-25 |
| 2018-09-30 | $20.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $40.72M derived: sum of 2 quarters · filed 2019-10-31 | $61.16M 10-Q · filed 2019-10-31 | $83.18M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $20.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $40.99M 10-Q · filed 2019-08-01 | $63.01M derived: sum of 3 quarters · filed 2020-02-27 | $82.71M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $20.44M 10-Q · filed 2019-05-02 | $42.46M derived: sum of 2 quarters · filed 2020-02-27 | $62.16M derived: sum of 3 quarters · filed 2020-02-27 | $80.40M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $22.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $41.72M derived: sum of 2 quarters · filed 2020-02-27 | $59.96M derived: sum of 3 quarters · filed 2020-02-27 | $75.53M 10-K · filed 2020-02-27 |
| 2017-09-30 | $19.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $37.94M derived: sum of 2 quarters · filed 2018-11-06 | $53.51M 10-Q · filed 2018-11-06 | $68.93M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $18.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $33.81M 10-Q · filed 2018-08-08 | $49.23M derived: sum of 3 quarters · filed 2019-02-27 | $63.24M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $15.57M 10-Q · filed 2018-05-04 | $30.99M derived: sum of 2 quarters · filed 2019-02-27 | $45.00M derived: sum of 3 quarters · filed 2019-02-27 | $58.88M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $15.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $29.43M derived: sum of 2 quarters · filed 2019-02-27 | $43.31M derived: sum of 3 quarters · filed 2019-02-27 | $55.27M 10-K · filed 2019-02-27 |
| 2016-09-30 | $14.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $27.89M derived: sum of 2 quarters · filed 2017-11-07 | $39.85M 10-Q · filed 2017-11-07 | $48.75M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $13.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $25.84M 10-Q · filed 2017-08-08 | $34.74M derived: sum of 3 quarters · filed 2018-02-27 | $44.01M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $11.96M 10-Q · filed 2017-05-09 | $20.86M derived: sum of 2 quarters · filed 2018-02-27 | $30.12M derived: sum of 3 quarters · filed 2018-02-27 | $37.62M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $18.17M derived: sum of 2 quarters · filed 2018-02-27 | $25.67M derived: sum of 3 quarters · filed 2018-02-27 | $40.19M 10-K · filed 2018-02-27 |
| 2015-09-30 | $9.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $16.76M derived: sum of 2 quarters · filed 2016-11-07 | $31.29M 10-Q · filed 2016-11-07 | $35.94M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $22.03M 10-Q · filed 2016-08-04 | $26.67M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $14.53M 10-Q · filed 2016-05-05 | $19.17M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $16.04M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $11.39M 10-Q · filed 2015-11-05 | |||
| 2014-03-31 | $3.16M 10-Q · filed 2014-05-06 | $5.34M derived: sum of 2 quarters · filed 2016-02-29 | $7.24M derived: sum of 3 quarters · filed 2016-02-29 | $8.34M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $4.07M derived: sum of 2 quarters · filed 2016-02-29 | $5.17M derived: sum of 3 quarters · filed 2016-02-29 | $5.71M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.90M 10-Q · filed 2013-11-06 | $3.00M derived: sum of 2 quarters · filed 2013-11-06 | $3.54M 10-Q · filed 2013-11-06 | $4.13M derived: sum of 4 quarters · filed 2014-05-06 |
| 2013-06-30 | $1.10M 10-Q · filed 2013-08-06 | $1.65M 10-Q · filed 2013-08-06 | $2.23M derived: sum of 3 quarters · filed 2014-05-06 | $2.72M derived: sum of 4 quarters · filed 2014-05-06 |
| 2013-03-31 | $582.00K 10-Q · filed 2014-05-06 | $1.13M derived: sum of 2 quarters · filed 2014-05-06 | $1.62M derived: sum of 3 quarters · filed 2014-05-06 | $2.10M derived: sum of 4 quarters · filed 2014-05-06 |
| 2012-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.04M derived: sum of 2 quarters · filed 2014-02-27 | $1.52M derived: sum of 3 quarters · filed 2014-02-27 | $1.93M 10-K · filed 2014-02-27 |
| 2012-09-30 | $488.00K 10-Q · filed 2013-11-06 | $966.00K derived: sum of 2 quarters · filed 2013-11-06 | $1.38M 10-Q · filed 2013-11-06 | $1.79M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $478.00K 10-Q · filed 2013-08-06 | $891.00K 10-Q · filed 2013-08-06 | $1.30M derived: sum of 3 quarters · filed 2014-02-27 | $1.70M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $413.00K 10-Q · filed 2013-05-07 | $821.00K derived: sum of 2 quarters · filed 2014-02-27 | $1.22M derived: sum of 3 quarters · filed 2014-02-27 | $1.64M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $809.00K derived: sum of 2 quarters · filed 2014-02-27 | $1.22M derived: sum of 3 quarters · filed 2014-02-27 | $1.60M 10-K · filed 2014-02-27 |
| 2011-09-30 | $401.00K 10-Q · filed 2012-11-05 | $814.00K derived: sum of 2 quarters · filed 2012-11-05 | $1.19M 10-Q · filed 2012-11-05 | $1.52M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $413.00K 10-Q · filed 2012-08-08 | $789.00K 10-Q · filed 2012-08-08 | $1.12M derived: sum of 3 quarters · filed 2013-03-12 | $1.52M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $375.00K 10-Q · filed 2012-05-08 | $711.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.10M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $729.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.58M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.25M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $854.00K 10-Q · filed 2011-08-10 | |||
| 2009-12-31 | $2.13M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |